We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Improve Approvals of Cancer Diagnostics, Industry Group Urges FDA
Improve Approvals of Cancer Diagnostics, Industry Group Urges FDA
The Friends of Cancer Research (FOCR) is urging the FDA to better coordinate simultaneous approval of new cancer drugs and companion diagnostics, and to focus on more speedy approval of diagnostics for rare cancer biomarkers.